Recap: Aspira Womens Health Q2 Earnings
Shares of Aspira Womens Health (NASDAQ:AWH) rose 7.6% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 50.00% year over year to ($0.06), which were in line with the estimate of ($0.06).
Aspira Womens Health Q2 EPS $(0.06), Inline, Sales $1.80M Beat $1.61M Estimate
Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 50 percent decrease over losses of $(0.04) per share from the same period last year.
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
Aspira Women’s Health Highlights Coverage For OVA1 In AIM Specialty Health Laboratory Medicine Clinical Guidelines
Aspira Women's Health Inc. (NASDAQ:AWH) today announced its OVA1® risk assessment test for ovarian cancer in women with pelvic masses is considered medically necessary according to AIM Specialty Health's
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell
• CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.